drugset / Trial / NCT05418244

Inhaled Isopropyl Alcohol for Treatment of Nausea

NCT05418244

Phase 2/3 Recruiting 84 enrolled State University of New York at Buffalo
RandomizedParallel-groupOpen-labelTreatment

Summary

To determine the efficacy of inhaled isopropyl alcohol in treating nausea/vomiting among pediatric patients compared with the conventional ondansetron, or placebo treatment in a tertiary care pediatric emergency department.

Timeline

Start
2022-04-20
Primary completion
2026-06-30
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ondansetron Other / unclassified 4 mg Oral

Indications

No indication recorded.